Your browser doesn't support javascript.
loading
Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin-But not through altered drug metabolism in patients with type 2 diabetes.
Dunvald, Ann-Cathrine Dalgård; Nielsen, Flemming; Olsen, Dorte Aalund; Ernst, Martin Thomsen; Donnelly, Louise; Soto-Pedre, Enrique; Kristiansen, Maja Refshauge; Nielsen, Jens Steen; Persson, Frederik; Højlund, Kurt; Madsen, Jonna Skov; Søndergaard, Jens; Pearson, Ewan; Pottegård, Anton; Stage, Tore Bjerregaard.
Afiliação
  • Dunvald AD; Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Nielsen F; Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Olsen DA; Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
  • Ernst MT; Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Donnelly L; Department of Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK.
  • Soto-Pedre E; Department of Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK.
  • Kristiansen MR; Steno Diabetes Center Odense (SDCO), Odense University Hospital, Odense, Denmark.
  • Nielsen JS; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Persson F; Steno Diabetes Center Odense (SDCO), Odense University Hospital, Odense, Denmark.
  • Højlund K; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Madsen JS; Steno Diabetes Center Copenhagen, Herlev Hospital, Herlev, Denmark.
  • Søndergaard J; Steno Diabetes Center Odense (SDCO), Odense University Hospital, Odense, Denmark.
  • Pearson E; Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
  • Pottegård A; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Stage TB; Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Br J Clin Pharmacol ; 89(8): 2529-2541, 2023 08.
Article em En | MEDLINE | ID: mdl-36967527
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Dinamarca